We are pleased to announce details of a new OBN Digital BioTuesday that will be addressing the topic of: ‘How Disruptive will RNA Technology be in Discovery and Development of Vaccines and Novel Therapies’

During this session, delivered in collaboration with Bruntwood SciTech on 23 March, we will hear from some of the most exciting R&D companies using RNA technology in their product development - please see below for more details.

We are delighted to be able to offer complimentary tickets for OBN Members and Bruntwood SciTech Associates, with a nominal fee of £25+VAT for Non-Members - simply click on the button to book.
Event Details:
17:00  Welcome & Introduction: 
Dr Kath Mackay, Managing Director, Bruntwood SciTech's Alderley Park
17:05  Keynote One: 
Dr David Blakey, SVP Strategic Alliances, MiNA Therapeutics
17:20  Keynote Two: 
Arvind Hundal, SVP Business Development at BioNTech
17:35  Company One:
17:45  Company Two:
17:55 Company Three:
Dr Martin Main, Head of Molecular Technologies, Medicines Discovery Catapult
18:05  Q&A
18:20  Virtual Networking via Remo
19:00  Event Close
This session will be run in a live format using Zoom Webinar, with registration open for both OBN Members and Non-Members. 
A live Q&A will follow the presentations and audience members will be encouraged to engage with speakers by sending their questions in during the event.
If you have any queries, then please contact: events@obn.org.uk

We look forward to welcoming you!

Best wishes

The OBN Team
Thank you to our OBN Corporate Sponsors